Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
aimed, Algorithm, ATO, AUD, Biotech, Biovitrum, BV, cohort, CytoDyn, detailed, differentiated, Dr, durable, Eli, EQUATE, expedited, expenditure, frontline, Gilead, greatest, heading, heard, Humanigen, immunology, importantly, Johnson, Lilly, Magic, mechanism, Moderna, Novavax, OncoImmune, Pfizer, Pharma, pharmacodynamic, resign, Sanofi, Sinovac, successor, Swedish, underwritten, VGPR
Removed:
activation, comorbid, screen, slower
Filing tables
Filing exhibits
Related press release
EQ similar filings
Filing view
External links